UNSPSC 51183103: Benfluorex

This classification denotes an anti-lipidemic agent and anorexiant with the molecular formula C19H20F3NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 403FO0NQG3, chemically known as phenethylamine, n-(2-hydroxyethyl)-alpha-methyl-m-trifluoromethyl-, benzoate but more generally known as benfluorex, which bears US NIH Compound Identifier 2318. Benfluorex most often comes in base and hydrochloride forms.

UNSPSC 51183103 Benfluorex is a Commodity code that in practice describes participation in multistate cooperative purchasing agreements for generic pharmaceuticals and over-the-counter products distributed to state and local government facilities. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents the primary issuing body for this code's recent activity. Manufacturers responding to cooperative agreements supply products through authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health, and Morris & Dickson Co., LLC) and must comply with current Good Manufacturing Practices (cGMP), the Drug Supply Chain Security Act (DSCSA), FDA requirements, and maintain insurance coverage including commercial general liability of $5,000,000 per occurrence and network security and privacy liability of $2,000,000. Vendors negotiate pricing through fixed-price, net-price, or WAC-minus formats and agree to a 3 percent administrative fee on all contract purchases. The code captures pharmaceutical manufacturing and supply agreements serving multiple state and local jurisdictions through a single procurement vehicle rather than individual agency solicitations.

MMCAP's January 2026 RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802, due March 26, 2026) represents the most recent documented opportunity under this code, covering participating state and local government facilities in Minnesota and Oregon. Evaluation criteria weight price competitiveness at 75 percent, with the remaining 25 percent distributed across fixed pricing, compliance with data-format requirements, EDI capability, and agreement to the administrative fee structure. The contract term runs two years for new vendors with optional MMCAP extensions, while incumbent vendors' amendments align with existing expiration dates through June 30, 2028. All products must be available in the marketplace by May 15, 2026, with resulting agreements effective July 1, 2026. No specific set-aside designations or restrictions limiting responses to particular business classifications appear in the available documentation.